The results of NP can be combined into a multi-marker approach, including (e.g.)interleukin and CRP, to identify target organ damage caused by hypertension in the heart, kidney and brain, to help facilitate early diagnosis of hypertension-mediated organ damage. This evidence concerns the gene CRP and hypertensive disorder.